Premium listings
  • Characterization and functional analysis of a novel cancer-associated gene

    Characterization and functional analysis of a novel cancer-associated gene

    PhD Studentships Liverpool May 15, 2016 Check with publisher

    Genes involved in common biological processes and diseases tend to be co-expressed. Therefore, genes co-expressed with known disease-associated genes will help identify new candidates for further studies. Our lab has recently developed a co-expressio...

  • Expertise in genomics and transcriptomics

    Expertise in genomics and transcriptomics

    Data Analysis - Analytics August 24, 2015 Check with publisher

    I lead the Integrative Genomics of Ageing Group (http://pcwww.liv.ac.uk/~aging/), and I have extensive experience in data analysis and integration of multidimensional data. Although my lab’s research integrates different strategies, its focal point i...

  • DrugAge database of compounds that increase lifespan

    DrugAge database of compounds that increase lifespan

    Biomedical Sciences Liverpool August 24, 2015 Check with publisher

    We're starting a new database of drugs and compounds (including natural products) with anti-ageing properties that extend longevity in model organisms. The database will be called DrugAge, and although we have some data already, we are looking for da...

Listings
  • Pack of 10 - Ethical Hacking & Penetration Testing Certification Bundle

    Pack of 10 - Ethical Hacking & Penetration Testing Certification Bundle

    IT fremont (California) August 7, 2020 145.00 Dollar US$

    Courses Included In The Bundle Ultimate Ethical Hacking Boot Camp - Beginner to Pro Ultimate Ethical Hacking Boot Camp - Beginner to Pro Welcome to The Ultimate Ethical Hacking Boot Camp. Learn Ethical Hacking from a world famous Ethical Hacker who h...

  • Felypressin Impurity E

    Felypressin Impurity E

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found...

  • Felypressin Impurity D

    Felypressin Impurity D

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found...

  • Felypressin Impurity C

    Felypressin Impurity C

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found...

  • Felypressin Impurity B

    Felypressin Impurity B

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found...

  • Felypressin Impurity A

    Felypressin Impurity A

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    An impurity of Felypressin.Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found ...

  • Delmitide

    Delmitide

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    Delmitide is a TNF-alpha production inhibitor potentially for the treatment of chemotherapy-induced diarrhea. https://www.creative-peptides.com/product/delmitide-item-10-101-147-34916.html

  • ACT1

    ACT1

    Drug Development Shirley (New York) August 5, 2020 Check with publisher

    ACT1, a synthetic peptide designed to mimic the C-terminus of the gap junction protein connexin 43 (Cx43), with high binding specificity to the tight junction associated protein zona occludens (ZO-1). https://www.creative-peptides.com/product/act1-it...

  • KAI-1455

    KAI-1455

    Drug Development Shirley (New York) August 4, 2020 Check with publisher

    KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and ...

  • KAI-1678

    KAI-1678

    Drug Development Shirley (New York) August 4, 2020 Check with publisher

    KAI-1678 is an inhibitor of epsilon protein kinase C in the treatment of neuropathic pain in patients with PHN. https://www.creative-peptides.com/product/kai-item-10-101-144-34913.html

  • Delcasertib

    Delcasertib

    Drug Development Shirley (New York) August 4, 2020 Check with publisher

    Delcasertib,a Novel δ-Protein Kinase C Inhibitor,is composed of a selective δ-protein kinase C (δPKC) inhibitor peptide conjugated reversibly to the cell-penetrating peptide via a disulfide bond. https://www.creative-peptides.com/product/delcasertib-...

  • TAT-NR2B9c

    TAT-NR2B9c

    Drug Development Shirley (New York) August 4, 2020 Check with publisher

    Tat-NR2B9c (NA-1) is an peptide that inhibits PSD-95, thus disrupting binding to N-methyl-D-aspartate receptors (NMDARs) and neuronal nitric oxide synthases (nNOS) and reducing excitoxicity induced by cerebral ischemia. https://www.creative-peptides....